Swiss drugmaker Novartis to pay up to $1.5 ‌billion for U.K.-based biotechnology firm Myricx Bio in a deal expected to close in the second half of 2026 | Spyke

Syndicated from the fediverse. Read and engage on the original instance.

View original on lemmy.world

Mergers_Acquisitions·Mergers and Acquisitions (M&A)byInnerworld

Swiss drugmaker Novartis to pay up to $1.5 ‌billion for U.K.-based biotechnology firm Myricx Bio in a deal expected to close in the second half of 2026

https://www.reuters.com/legal/litigation/novartis-acquire-uk-based-myricx-bio-up-15-billion-2026-07-06/Open link View original on lemmy.world

1

No replies yet

No comments on the original post yet.

Swiss drugmaker Novartis to pay up to $1.5 ‌billion for U.K.-based biotechnology firm Myricx Bio in a deal expected to close in the second half of 2026 | Spyke